THIOLIN
DEAD

Serial Number

76096018

Owner

DE PAOLI AMBROSI, Gianfranco

Attorney

Jess M. Collen

Filing Date

Jul 25, 2000

Add to watchlist:

No watchlists yet
View on USPTO

THIOLIN Trademark

Serial Number: 76096018 • Registration: 2745730

THIOLIN is a trademark filed by DE PAOLI AMBROSI, Gianfranco on July 25, 2000. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

DE PAOLI AMBROSI, Gianfranco (9 trademarks)

Via Cure del Lino 32
SALO' ( Brescia ) , IT

Entity Type: 98

Trademark Details

Filing Date

July 25, 2000

Registration Date

August 5, 2003

Published for Opposition

May 13, 2003

Cancellation Date

March 7, 2010

Goods & Services

COSMETICS, NAMELY, SOAP, PERFUMES, ESSENTIAL OILS FOR PERSONAL USE, HAIR LOTIONS, SKIN LOTION, BODY LOTION, FACE LOTION, SHAMPOO, FACE CREAM, BODY CREAM, SKIN CREAM, SKIN CLEANSING MILK, SHAMPOO, TOOTHPASTE, BODY POWDER, SKIN POWDER AND FACE POWDER, FOUNDATION POWDER, FOUNDATION MAKE-UP, AND BLUSH

pharmaceutical preparations for the treatment of atopic dermatitides,seborrheic dermatitides, nummular dermatitides, exfoliative dermatitides, stasis dermatitides, neurodermatitides, acne, acne rosacea, cicatricial alopecia, hippocratic alopecia, female alopecia, drug-induced toxic alopecia, alopecia areata, erythema, pseudofolliculitides, psoriasis, lichen ruber planus, ichthyosis, xeroderma, keratosis polaris, decubital ulcers, trophic ulcers, torpid sores,angiomas, vascular nevi or stars, hemangiomas, telangiectatic granuloma,seborrheic keratosis, fibrous histiocytoma, morphea, treatment of hypertrophic scars, burn scars, telangiectasia, changes in the circulation and in the microcirculation, venous stasis, circulatory stasis, lupus erythematosus, topical treatment of scleroderma, scarring from wounds, keloids, in the treatment of the degenerative forms of the amorphous component of tissues, circulatory stasis,venous stasis and arterial stasis, rheumatoid arthritis, osteoarthritis, arthrosis,sclerodema, intoxication of the radical oxygen species; pharmaceutical preparations for the treatment and prevention of skin hyperpigmentations;pharmaceutical preparations for the treatment of degenerative forms related to damage caused by oxidative stress

CHEMICALS, NAMELY, FATTY ACIDS, NAMELY MIXTURE OF FATTY ACIDS OR ESTERS OF FAT ACIDS, AND LIPOTIC ACID FOR USE IN PHARMACEUTICAL PREPARATIONS

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 7, 2010 C8..
CASE FILE IN TICRS
Jan 14, 2008 CFIT
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2003 R.PR
PUBLISHED FOR OPPOSITION
May 13, 2003 PUBO
NOTICE OF PUBLICATION
Apr 23, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 14, 2003 CRFA
PAPER RECEIVED
Feb 14, 2003 MAIL
INQUIRY AS TO SUSPENSION MAILED
Sep 11, 2002 CNSI
LETTER OF SUSPENSION MAILED
Nov 16, 2001 CNSL
ASSIGNED TO EXAMINER
Nov 2, 2001 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2001 CRFA
NON-FINAL ACTION MAILED
Jan 18, 2001 CNRT
ASSIGNED TO EXAMINER
Jan 6, 2001 DOCK
ASSIGNED TO EXAMINER
Jan 3, 2001 DOCK